Skip to content

Lopinavir/ritonavir cuts malaria risk in children with HIV

Lopinavir/ritonavir cuts malaria risk in children with HIV

Once-a-month HIV drug maintains good levels for prevention; few side-effects so far

Four doses of PrEP a week may be enough to protect

Detail from iPrEx materials (www.globaliprex.com).

FDA updates guidance for use of HIV and hepatitis C protease inhibitors with statins

Severe nevirapine rash linked to slow clearance of drug

Can speeding up nevirapine clearance reduce the risk of resistance after PMTCT use?

Guidelines published on management of interactions between anti-epileptic and anti-HIV drugs

Efavirenz may be under-dosed in children

Crushing Kaletra tablets for kids leads to lower drug levels